NAGE
Niagen Bioscience, Inc.
3.00$
+0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +703,884.5% | -12.7% | +82.5% | -3.6% | +44.1% | -0.5% | +28.2% | +62.8% | +5.3% | +217.6% | -32.7% | -4.7% | -4.7% | +50.8% | -6.5% | +1.7% | +24.2% | +55.8% | |
| – | +396,236.0% | -12.7% | +143.8% | +1.2% | +60.0% | -27.0% | +70.9% | +67.2% | -4.9% | +263.3% | -36.1% | -8.3% | -3.9% | +51.8% | -4.8% | +6.4% | +29.4% | +51.0% | |
| – | +193,952.4% | -58.1% | +372.3% | -81.1% | +23.8% | +334.9% | +75.3% | +40.0% | -70.4% | +2,663.5% | -50.6% | -17.0% | -11.4% | +69.8% | -27.6% | +33.9% | +63.8% | +45.6% | |
| – | +193,952.4% | -58.1% | +372.3% | -81.1% | +23.8% | +334.9% | +75.3% | +40.0% | -70.4% | +2,663.5% | -50.6% | -17.0% | -11.4% | +69.8% | -27.6% | +33.9% | +63.8% | +45.6% | |
| – | – | +42.7% | +101.1% | -27.7% | +168.2% | -45.7% | +80.9% | +28.5% | +138.8% | -8.8% | -17.3% | -50.7% | +23.9% | +94.0% | +62.3% | -38.3% | +48.4% | +25.4% | |
| – | – | +29.7% | +54.2% | +104.2% | +79.1% | -57.7% | +69.4% | +118.9% | -3.2% | -26.8% | +42.3% | +39.8% | +1.3% | +16.4% | +7.9% | -1.0% | -36.7% | +122.2% | |
| – | – | -27.8% | -13.6% | -64.0% | +36.0% | +48.1% | +46.8% | +19.6% | +37.3% | +239.7% | -6.3% | -15.3% | -17.5% | -20.8% | -21.7% | -24.0% | -29.6% | +1,476.6% | |
| – | +583,386.8% | +7.9% | -37.6% | +136.0% | +35.9% | -34.1% | +126.4% | +79.2% | -27.4% | -9.1% | +69.3% | +31.5% | +10.8% | +19.1% | -2.8% | +4.4% | -16.3% | +34.7% | |
| – | +518,232.8% | +5.5% | -47.9% | +193.4% | +42.5% | -40.4% | +75.5% | +92.5% | -7.5% | -8.8% | +78.5% | +4.3% | +9.4% | +6.9% | +1.5% | +15.4% | -13.0% | +11.0% | |
| – | – | -63.8% | +176.4% | -1.6% | -0.1% | +79.8% | +167.6% | +370.4% | -85.4% | -23.3% | -11.7% | +393.1% | -27.3% | -11.6% | +27.0% | +0.9% | +41.6% | +0.8% | |
| – | +110,984.3% | +23.4% | -6.1% | +337.3% | +52.3% | -58.0% | +139.5% | +80.3% | -3.9% | -37.8% | +156.7% | +0.8% | -1.9% | +10.4% | -7.1% | +5.7% | -16.7% | +26.6% | |
| – | +971,657.2% | -40.1% | +371.3% | -48.1% | +55.9% | +41.9% | -29.4% | +31.9% | +89.1% | +439.7% | -49.5% | -24.8% | -19.7% | +93.2% | -9.6% | -0.8% | +62.0% | +66.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +76.5% | +1.9% | +67.3% | +41.6% | +40.5% | +4.2% | +6.5% | +1.1% | +3.9% | +19.6% | +23.3% | +3.7% | +7.0% | +10.0% | +3.8% | +7.5% | +6.3% | +7.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.